Cycloastragenol 环黄芪醇; Astramembrangenin; Cyclosieversigenin,98.0%
产品编号:Bellancom-N1485| CAS NO:78574-94-4| 分子式:C30H50O5| 分子量:490.72
Astramembrangenin 环黄芪醇是一种三萜皂苷化合物,是黄芪 (Astragalus membranaceus (Fisch.) Bunge) 中活性成分的水解产物。Astramembrangenin 具有口服安全性,具有广泛的药理学作用,包括端粒酶活化,端粒延长,抗炎和抗氧化特性。Astramembrangenin 具有抗衰老特性,CAG 刺激人新生角质形成细胞和大鼠神经细胞中的端粒酶活性,并诱导 CREB 活化。 Astramembrangenin 可能在抑郁症中具有新的治疗作用。
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Cycloastragenol 环黄芪醇; Astramembrangenin; Cyclosieversigenin
产品介绍 | Cycloastragenol (Astramembrangenin) 是 astragaloside IV的活性形式,具有抗氧化、抗炎、抗衰老、抗凋亡和心血管保护作用。Cycloastragenol是一种有效的端粒酶 (telomerase) 激活剂,可以延长端粒。Cycloastragenol 缓解与年龄相关的骨丢失,改善骨微结构和生物力学特性。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | Cycloastragenol (Astramembrangenin), the active form of astragaloside IV, has anti-oxidant, anti-inflammatory, anti-aging, anti-apoptotic, and cardiovascular protective effects. Cycloastragenol is a potent telomerase activator and can lengthen telomeres. Cycloastragenol alleviates age-related bone loss and improves bone microstructure and biomechanical properties. | ||||||||||||||||
体外研究 |
Cycloastragenol (0.03-3 μM; 24-72 hours) promotes viability, osteoblastic differentiation, and mineralization in MC3T3-E1 cells. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
Cycloastragenol (5, 10, 20 mg/kg) is injected intraperitoneally at the onset of reperfusion, 12 h later and then twice daily for up to three days. Cycloastragenol dose-dependently reduces brain infarct volume, significantly ameliorated functional deficits, and prevents neuronal cell loss in middle cerebral artery occlusion (MCAO) mice. Cycloastragenol suppresses the mRNA expression of pro-inflammatory cytokines, including TNF-α and IL-1β, and inhibits the activation of microglia and astrocytes in the ischemic brain. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
Cycloastragenol (5, 10, 20 mg/kg) is injected intraperitoneally at the onset of reperfusion, 12 h later and then twice daily for up to three days. Cycloastragenol dose-dependently reduces brain infarct volume, significantly ameliorated functional deficits, and prevents neuronal cell loss in middle cerebral artery occlusion (MCAO) mice. Cycloastragenol suppresses the mRNA expression of pro-inflammatory cytokines, including TNF-α and IL-1β, and inhibits the activation of microglia and astrocytes in the ischemic brain. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 66.67 mg/mL (135.86 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
| ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||||||||
参考文献 |
|
危险品运输编码 | NONH for all modes of transport |
---|---|
RTECS号 | GX8265000 |
海关编码 | 2942000000 |

匹配竞争对手的价格

效率为先

专业经验 贴心服务

50000+库存